Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sharpe

Showing results (191-200 of 213) with videos related to

Pageof 22
Sort By:
Applied and Environmental Microbiology|January 22, 1998
Measurement of antimicrobial-resistant Escherichia coli in pig feces with a hydrophobic grid membrane filter interpreter systemR H Dunlop, S A McEwen, A H Meek, et al.
Lancet (London, England)|October 20, 1984
Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranololR M Norris, P F Barnaby, M A Brown, et al.
Lancet (London, England)|July 2, 1988
Patent foramen ovale in young stroke patientsM W Webster, A M Chancellor, H J Smith, et al.
Journal of Nephrology|January 1, 1997
Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis. The Perfect Study Collaborative GroupR Robson, J Collins, R Johnson, et al.
Circulation|February 17, 1999
Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure GroupA M Richards, R Doughty, M G Nicholls, et al.
Canadian Journal of Microbiology|October 1, 1983
Collaborative study of the MPN, Anderson-Baird-Parker direct plating, and hydrophobic grid-membrane filter methods for the enumeration of Escherichia coli biotype I in foodsA N Sharpe, M K Rayman, D M Burgener, et al.
Journal of the American College of Cardiology|June 13, 2001
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure GroupA M Richards, R Doughty, M G Nicholls, et al.
Lancet (London, England)|June 24, 1995
Association of angiotensinogen gene T235 variant with increased risk of coronary heart diseaseT Katsuya, G Koike, T W Yee, et al.
The New Zealand Medical Journal|May 11, 1983
Coronary heart disease: prevention and control in 1983D R Hay, R Beaglehole, J F Gwynne, et al.
The New Zealand Medical Journal|July 12, 1996
Management of acute myocardial infarction in AucklandJ French, B Williams, H Hart, et al.
Pageof 22

Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
Applied and Environmental Microbiology|January 22, 1998
Measurement of antimicrobial-resistant Escherichia coli in pig feces with a hydrophobic grid membrane filter interpreter systemR H Dunlop, S A McEwen, A H Meek, et al.
Lancet (London, England)|October 20, 1984
Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranololR M Norris, P F Barnaby, M A Brown, et al.
Lancet (London, England)|July 2, 1988
Patent foramen ovale in young stroke patientsM W Webster, A M Chancellor, H J Smith, et al.
Journal of Nephrology|January 1, 1997
Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis. The Perfect Study Collaborative GroupR Robson, J Collins, R Johnson, et al.
Circulation|February 17, 1999
Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure GroupA M Richards, R Doughty, M G Nicholls, et al.
Canadian Journal of Microbiology|October 1, 1983
Collaborative study of the MPN, Anderson-Baird-Parker direct plating, and hydrophobic grid-membrane filter methods for the enumeration of Escherichia coli biotype I in foodsA N Sharpe, M K Rayman, D M Burgener, et al.
Journal of the American College of Cardiology|June 13, 2001
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure GroupA M Richards, R Doughty, M G Nicholls, et al.
Lancet (London, England)|June 24, 1995
Association of angiotensinogen gene T235 variant with increased risk of coronary heart diseaseT Katsuya, G Koike, T W Yee, et al.
The New Zealand Medical Journal|May 11, 1983
Coronary heart disease: prevention and control in 1983D R Hay, R Beaglehole, J F Gwynne, et al.
The New Zealand Medical Journal|July 12, 1996
Management of acute myocardial infarction in AucklandJ French, B Williams, H Hart, et al.
Pageof 22